BaiyaPhytopharm Announces Preliminary Results of the Phase 1 Clinical Trial of its COVID-19 Vaccine Baiya SARS-CoV-2 Vax 2
Study Design The ongoing phase 1 trial is a dose-escalating open-label study to evaluate the Baiya SARS-CoV-2 Vax2 vaccine in…
News & Events
August 25, 2022 Baiya’s CEO was interviewed on CNBC’s “Managing Asia” about “A Thai start-up is working on a Covid vaccine — using tobacco leaves”
The start-up, founded by Dr. Suthira Taychakhoonavudh and Dr. Waranyoo Phoolcharoen in 2018, has been working on a vaccine using…
January 17, 2022 Baiya’s co-founders have been interviewed by the press association Sky news about the topic of “Scientists in Thailand using tobacco leaves to develop plant-based vaccine to fight Omicron”.
“COVID-19 is not going to be the last one, right? You’re going to have so many emerging diseases and if…
December 21, 2021 Chula Radio plus has released a new SoundCloud with the topic of “Emerging Infectious Diseases & Search for New Vaccines”
Emerging infectious diseases are defined as diseases in which incidence in humans has increased in the past two decades, or…
September 25, 2021
